Product Information
BRIMONIDINE 0.2% EYE DROP is a generic product labeled by Somerset Therapeutics, LLC, priced at $0.8530 per ML under NDC 70069023101. Its NADAC has been published 374 times since Aug 7, 2019.
FDA first approved this application on Mar 11, 2019. Its Orange Book therapeutic-equivalence code is AT.
Strength
2 mg/mL
Manufacturer
Somerset Therapeutics, LLCNDC
70069023101
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
BRIMONIDINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA208992FDA Approved
3/11/2019
TE Code
AT
On Market Since
3/11/2019
Pharmacological Classes
Price Statistics
The NADAC for BRIMONIDINE 0.2% EYE DROP has been published 374 times since Aug 7, 2019, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8530 per ML |
|---|---|
| All-time high | $0.9708 (Nov 13, 2019) |
| All-time low | $0.6907 (May 22, 2024) |
| 52-week high | $0.8530 |
| 52-week low | $0.7695 |
| Median price | $0.8411 |
| Average price | $0.8311 |
| Largest weekly change | +25.0% (Jun 19, 2024) |
| Weeks tracked | 374 |
| Tracking since | Aug 7, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 41% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Somerset Therapeutics, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
BRIMONIDINE TARTRATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BRIMONIDINE 0.2% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE 0.2% EYE DROP, manufactured by Somerset Therapeutics, LLC, is $0.8530 per ML (NDC 70069023101), effective Sep 30, 2026.
How has the price of BRIMONIDINE 0.2% EYE DROP changed over time?
Over the history we have for it, the NADAC for BRIMONIDINE 0.2% EYE DROP has held within roughly two percent of its current level. It has been tracked across 374 weekly CMS publications since Aug 7, 2019.
What are the highest and lowest recorded NADAC prices for BRIMONIDINE 0.2% EYE DROP?
Since Aug 7, 2019, the NADAC for BRIMONIDINE 0.2% EYE DROP has ranged from a low of $0.6907 (May 22, 2024) to a high of $0.9708 (Nov 13, 2019), with a median of $0.8411 per ML.
Are there cheaper alternatives to BRIMONIDINE 0.2% EYE DROP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRIMONIDINE 0.2% EYE DROP, is $0.5012 per ML — about 41% below BRIMONIDINE 0.2% EYE DROP.
Who manufactures BRIMONIDINE 0.2% EYE DROP?
BRIMONIDINE 0.2% EYE DROP (NDC 70069023101) is labeled by Somerset Therapeutics, LLC, and CMS classifies it as a generic product.